First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction. Miyagawa A, Adachi T, Takamiyagi S, Arakawa H, et al. J Dermatol 2021;48:e221-e222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Miyagawa A, Adachi T, Takamiyagi S, Arakawa H, et al. First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction. J Dermatol 2021;48:e221-e222.
PMID: 33651422